International Journal of

Allergy MedicationsISSN: 2572-3308

Current Issue

 Open Access DOI:10.23937/2572-3308.1510041

Clinical and Spirometric Characteristics of Premenstrual Asthma

S Aissani, I Ararem, H Haouichat, ME Haffaf and A Zitouni

Article Type: Research Article | First Published: June 06, 2019

Premenstrual asthma (APM) is often confused by the patient and/or doctor with the symptoms of asthma in general. The purpose of our study is to investigate the clinical and spirometric characteristics of APM. Prospective descriptive study from 2011 to 2017, on 95 non-menopausal asthma patients, divided into 2 with and without APM. They benefited on a single menstrual cycle of spirometry during the follicular phase, luteal and premenstrual and cutaneous tests....

 Open Access DOI:10.23937/2572-3308.1510040

Anaphylaxis to Water Caltrop (Singoda Flour): A Case Report

Omar E Mohamed, Toni Osborne, Jane Heslegrave and Mamidipudi Thirumala Krishna

Article Type: Case Report | First Published: May 25, 2019

A 57-year-old gentleman of an Asian background developed generalised urticaria, breathlessness and loss of consciousness following ingestion of Singoda flour (water caltrop flour). He was successfully resuscitated with adrenaline, chlorpheniramine and hydrocortisone. Acute mast cell tryptase was elevated and the skin prick test to water caltrop seed was positive. ...

 Open Access DOI:10.23937/2572-3308.1510039

Anti-IgE (Omalizumab) in the Management of ABPA among Cystic Fibrosis Patients: An Alternative to Steroid Treatment?

Marianne Skov

Article Type: Short Communication | First Published: May 25, 2019

Airway colonization with Aspergillus species, typically A. fumigatus, is frequent among cystic fibrosis (CF) patients. A subgroup of the patients develops allergic bronchopulmonary aspergillosis (ABPA) - an immunological reaction directed against the fungal infection with serious clinical consequences for the patients. Between one and 15% of the CF population is reported to be affected by ABPA....

 Open Access DOI:10.23937/2572-3308.1510038

The Burden of Allergic Rhinitis and Impact of GRAZAX Grass Allergy Immunotherapy Treatment on Quality of Life in Germany and The Netherlands: Results from A Qualitative Study

Germain N, Gerth van Wijk R, Aballea S, Abetz-Webb L, Domdey A, Romano M and Toumi M

Article Type: Research Article | First Published: April 03, 2019

Allergic rhinitis is a major chronic respiratory disease that affects between 10% and 30% of adults and up to 40% of children globally. The purpose of this study was to understand the impact of allergic rhinitis and subsequent GRAZAX grass allergy immunotherapy (AIT) treatment on adults' and adolescents' quality of life. Clinicians treating allergic rhinitis in the Netherlands and Germany recruited adults and adolescents who had received at least 3 years of GRAZAX® treatment. Telephone intervie...

 Open Access DOI:10.23937/2572-3308.1510037

H1-Antihistamines for Allergic Diseases: Old Aged but Not Old-Fashioned Drugs

Luisa Ricciardi, Fabiana Furci and Isola Stefania

Article Type: REVIEW ARTICLE | First Published: March 04, 2019

Histamine is a chemical messenger synthesized from the amino acid histidine by L-histidine decarboxylase. It plays an important role in the system of immunoregulation and in acute and chronic allergic inflammation binding to four subtypes of receptors H1, H2, H3 and H4, described as heptahelical transmembrane molecules that activate specific G-proteins. These receptors placed on the membranes of different cellular jambs (mast cells, endothelial cells, sensory nerve fibres, bronchial smooth muscl...

Volume 5
Issue 1